The information is updated the first week of every month - so ... make this a regular stop in your information gathering activities.The following information has been compiled from publicly available sources, StratCom does not assume any responsibility for the accuracy or the authenticity of the information and StratCom cannot be held liable for errors. StratCom takes this opportunity to wish our readers
NanoInk, Inc., has received the first award of a two-phase $1.3 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) to support the development of NanoInk's patented Dip Pen Nanolithography technology for ultra-miniaturization of DNA arrays. Specialty Laboratories has launched its Cystic Fibrosis 70 GenotypR, a new genetic screening test for Cystic Fibrosis (CF) and Cystic Fibrosis carrier status. The test screens for 70 of the most clinically important mutations of the CF gene found in US population groups. The test was developed in collaboration with Tm Bioscience Corporation.
Molecular Biology - October 2003
Product Developments Worldwide | Research News | Health Care in Canada Information Technology and Healthcare | Molecular Biology | Links
Send mail to stratcom@pagebleu.com with questions or comments about this web site.Concept and Design Blue Page
Productions Last modified: December 2, 2003 |